NOAH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient investor: momentum is weakening (negative, expanding MACD histogram) and the stock is trading below the pivot level (11.659).", "Near-term risk/reward is mixed: price is hovering close to support (S1 11.277 / S2 11.041), but options positioning skews defensive (put-heavy open interest).", "Without a fresh catalyst (no news) and with the only recent Street update being a price-target cut below the current price, the setup favors waiting/avoiding new entries today."]
["Trend/MAs: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) suggests the broader trend structure is still constructive.", "Momentum: MACD histogram -0.0392 is below zero and negatively expanding \u2192 bearish momentum building short-term.", "RSI: RSI_6 at 34.266 indicates the stock is getting close to oversold territory (weak demand), but not a confirmed reversal signal.", "Levels: Pivot 11.659 overhead is the key reclaim level; immediate support is S1 11.277 then S2 11.041. With price ~11.205, it is already under S1 (a near-term negative).", "Pattern odds (model): 40% chance of +3.58% next day / +3.46% next week; suggests upside is possible, but not high-confidence.", "Intellectia Proprietary Trading Signals", "- AI Stock Picker: no signal on given stock today.", "- SwingMax: No signal on given stock recently."]
["Flow/support: Hedge funds are buying; buying amount up 112.32% over the last quarter.", "Downside support narrative (per UBS): high dividend yield (~16%) and sizable cash/short-term investments (Rmb5.0B) cited as a cushion.", "Profitability: Latest reported quarter shows strong earnings growth (net income and EPS sharply higher YoY)."]
points to defensive positioning.", "No near-term news catalysts in the last week to spark a quick re-rating.", "UBS noted higher provision expenses and contingent-liability overhang as sentiment headwinds."]
["Latest quarter: 2025/Q3.", "Revenue: 632,899,000 (down -7.43% YoY) \u2192 top-line contraction.", "Net income: 218,494,000 (up +62.55% YoY) \u2192 strong bottom-line improvement despite revenue decline.", "EPS: 0.62 (up +63.16% YoY) \u2192 earnings growth is the standout positive.", "Overall: improving profitability with weakening revenue; quality of earnings matters, but growth is not broadly accelerating."]
["Most recent update (2025-12-22): UBS kept a Neutral rating and lowered price target to $10 from $11.", "Rationale: higher provision expenses and ongoing sentiment overhang; contingent liabilities may weigh near-term.", "Wall Street pros: dividend yield (~16%) and cash/short-term investments (Rmb5.0B) seen as downside protection.", "Wall Street cons: target below current price and stated overhangs imply limited upside and continued pressure until uncertainties clear."]
